Gary Loeb - Net Worth and Insider Trading
Gary Loeb Net Worth
The estimated net worth of Gary Loeb is at least $49,093 dollars as of 2024-04-27. Gary Loeb is the EVP, General Counsel & Sec. of Sangamo Therapeutics Inc and owns about 83,238 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $43,101. Gary Loeb is the See Remarks of Achaogen Inc and owns about 239,673 shares of Achaogen Inc (AKAOQ) stock worth over $5,992. Gary Loeb is also the SVP, Gen'l Counsel & Secretary of Amyris Inc and owns about 267 shares of Amyris Inc (AMRSQ) stock worth over $0. Details can be seen in Gary Loeb's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gary Loeb has not made any transactions after 2021-03-23 and currently still holds the listed stock(s).
Transaction Summary of Gary Loeb
Gary Loeb Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary Loeb owns 4 companies in total, including Sangamo Therapeutics Inc (SGMO) , Achaogen Inc (AKAOQ) , and Amyris Inc (AMRSQ) among others .
Click here to see the complete history of Gary Loeb’s form 4 insider trades.
Insider Ownership Summary of Gary Loeb
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SGMO | Sangamo Therapeutics Inc | 2021-03-23 | EVP & General Counsel |
AKAOQ | Achaogen Inc | 2019-02-21 | See Remarks |
AMRSQ | Amyris Inc | 2012-10-31 | SVP & Gen'l Counsel & Secretary |
ISRG | Intuitive Surgical Inc | 2022-10-10 | General Counsel & CCO |
Gary Loeb Latest Holdings Summary
Gary Loeb currently owns a total of 3 stocks. Among these stocks, Gary Loeb owns 83,238 shares of Sangamo Therapeutics Inc (SGMO) as of March 23, 2021, with a value of $43,101 and a weighting of 87.79%. Gary Loeb owns 239,673 shares of Achaogen Inc (AKAOQ) as of February 21, 2019, with a value of $5,992 and a weighting of 12.21%. Gary Loeb also owns 267 shares of Amyris Inc (AMRSQ) as of October 31, 2012, with a value of $0 and a weighting of 0%.
Latest Holdings of Gary Loeb
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGMO | Sangamo Therapeutics Inc | 2021-03-23 | 83,238 | 0.52 | 43,101 |
AKAOQ | Achaogen Inc | 2019-02-21 | 239,673 | 0.03 | 5,992 |
AMRSQ | Amyris Inc | 2012-10-31 | 267 | 0.00 | 0 |
Holding Weightings of Gary Loeb
Gary Loeb Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary Loeb has made a total of 1 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sangamo Therapeutics Inc is the sale of 17,524 shares on March 23, 2021, which brought Gary Loeb around $230,090.
According to the SEC Form 4 filings, Gary Loeb has made a total of 0 transactions in Achaogen Inc (AKAOQ) over the past 5 years. The most-recent trade in Achaogen Inc is the sale of 791 shares on February 21, 2019, which brought Gary Loeb around $704.
According to the SEC Form 4 filings, Gary Loeb has made a total of 0 transactions in Amyris Inc (AMRSQ) over the past 5 years. The most-recent trade in Amyris Inc is the sale of 0 shares on October 31, 2012, which brought Gary Loeb around $0.
Insider Trading History of Gary Loeb
- 1
Gary Loeb Trading Performance
Gary Loeb Ownership Network
Ownership Network List of Gary Loeb
Ownership Network Relation of Gary Loeb
Gary Loeb Owned Company Details
What does Sangamo Therapeutics Inc do?
Who are the key executives at Sangamo Therapeutics Inc?
Gary Loeb is the EVP & General Counsel of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .
Sangamo Therapeutics Inc (SGMO) Insider Trades Summary
Over the past 18 months, Gary Loeb made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.
Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sangamo Therapeutics Inc Insider Transactions
Gary Loeb Mailing Address
Above is the net worth, insider trading, and ownership report for Gary Loeb. You might contact Gary Loeb via mailing address: 5885 Hollis St., Suite 100, Emeryville Ca 94608.